Yüklüyor......
Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review
INTRODUCTION: Aliskiren is a newly developed medicine. As one of the effective renin–angiotensin–aldosterone system inhibitors, its role in lowering blood pressure has been recognised. However, its safety and tolerability still remain controversial. The aim of the paper is to systematically summaris...
Kaydedildi:
| Yayımlandı: | BMJ Open |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045264/ https://ncbi.nlm.nih.gov/pubmed/31969367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-033448 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|